Updated on 2024/05/03

写真a

 
KINOSHITA Yoshiaki
 
Organization
Academic Assembly Institute of Medicine and Dentistry IGAKU KEIRETU Professor
Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Regenerative and Transplant Medicine Professor
Title
Professor
External link

Degree

  • 医学博士 ( 2002.1   九州大学 )

Research History

  • Niigata University   Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Regenerative and Transplant Medicine   Professor

    2020.1

  • Niigata University   Faculty of Medicine School of Medicine   Associate Professor

    2018.4 - 2019.12

  • Niigata University   Graduate School of Medical and Dental Sciences Biological Functions and Medical Control Regenerative and Transplant Medicine   Research Assistant

    2002.4 - 2003.8

 

Research Projects

  • 小児良性固形腫瘍に対する免疫学的糖鎖解析法を用いた診断システムの開発

    Grant number:21K08661

    2021.4 - 2024.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    木下 義晶, 小林 隆, 高橋 良彰

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    小児の固形腫瘍は悪性疾患としては神経芽腫、肝芽腫、腎芽腫、横紋筋肉腫などが代表的である。一方、血管腫、リンパ管腫、良性の奇形腫(以下、胚細胞腫瘍)などの良性固形腫瘍は時として鑑別診断が難しく、その臨床像も多彩で、症例によっては巨大で重要臓器や血管をまきこみ外科的治療が困難である。特異的な腫瘍マーカーはなく、診断は画像診断に頼らざるをえない。正確な診断がつかなければ治療の導入が遅れ、良性腫瘍とはいっても時として予期せぬ転帰をたどることがある。良性腫瘍であるため、本来、外科治療が中心になるとされてきたが、近年外科治療以外の治療法として分子標的治療など様々な内科的治療の研究が進んでいる。本研究ではそれぞれの小児良性固形腫瘍の発生起源として候補に挙がっている遺伝子産物である糖鎖抗原蛋白を血清学的に診断可能にする免疫電気泳動法と質量分析法を用いた非侵襲的新規簡易診断システムの開発を目的とする。
    実際の研究の進め方に関しては、①小児良性固形腫瘍疾患および小児悪性固形腫瘍疾患を対象とした画像診断学的評価とGlut1, Podoplanin, Glypican3を用いた免疫組織学的解析、②特異的糖鎖抗原の同定とモノクローナル抗体の作製、③免疫電気泳動法による血清中のGlut1, Podoplanin, Glypican3の分離測定と質量分析法による定量化、④血清Glut1, Podoplanin, Glypican3発現量の測定と診断システムの確立、の4つの段階に分けて進める。①、②、③を令和3年度、4年度、5年度に順次進め、④に関しては令和5年度以降から着手し、それ以後の年度への研究継続への実績とすることを目標とする。令和3年度においては臨床症例のピックアップと画像評価としてのpreliminaryなデータ収集と解析を行った。

    researchmap

  • 致死的合併症であるIFALD予防を網羅した短腸症候群に対する新規細胞治療の確立

    Grant number:21K08639

    2021.4 - 2024.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    高橋 良彰, 木下 義晶, 小林 隆

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    短腸症候群やヒルシュスプルング病類縁疾患のような腸管不全患者は、長期間中心静脈栄養を要することが多く、腸管不全関連肝障害(IFALD)を高率に発症し、致命的となる。そのため、早期に中心静脈栄養からの離脱が重要である。しかし、離脱可能かどうかに関しては症例毎によって違い、様々な因子が関係している。
    昨年度は、まず、当科でフォローアップしている腸管不全患者について把握することを行った。中心静脈栄養からの離脱、IFALDの予防が重要であり、点滴離脱に関与する因子を明らかにすることを目的とした。離脱群と非離脱群に分けて、比較検討することとした。
    当院でフォローアップしている腸管不全患者は8例認めた。5例が短腸症候群で3例がヒルシュスプルング病類縁疾患であった。点滴を離脱した症例は4例で、離脱できない症例も4例認めた。半数は点滴離脱できていない結果であった。離脱できていない症例のうち3例(75%)がヒルシュスプルング病類縁疾患であった。つまり、ヒルシュスプルング病類縁疾患は全例離脱できておらず、リスク因子であった。また、結腸切除を施行された症例も有意に非離脱群に多く認めた。残存小腸の長さに関しては、離脱群、非離脱群に有意な差は認めなかった。血液検査に関しては、アルブミン、コリンエステラーゼ、セレン、カルニチンは両群間に有意さは認めなかった。必須脂肪酸に関しては、非離脱群では有意に欠乏していた。
    腸管不全関連肝障害に関しては、8例中5例に認めたが、ω3系脂肪酸投与などにより肝不全までは進行せず、生存していた。

    researchmap

  • セラミドによる免疫制御機構を応用した膵島移植における膵島生着延長の試み

    Grant number:20K21628

    2020.7 - 2023.3

    System name:科学研究費助成事業

    Research category:挑戦的研究(萌芽)

    Awarding organization:日本学術振興会

    小林 隆, 木下 義晶, 松田 康伸, 永橋 昌幸, 三浦 宏平, 廣瀬 雄己, 油座 築, 諸 和樹

      More details

    Grant amount:\6500000 ( Direct Cost: \5000000 、 Indirect Cost:\1500000 )

    本研究はセラミドによる免疫制御機構を応用した膵島移植における膵島生着延長を試みる研究である。脂質メディエーターの一種であるセラミドがTリンパ球の一種である制御性T細胞の機能維持に重要であるとの知見(Nat Immunol 2016)を踏まえ、1型糖尿病に対する細胞治療である膵島移植において、セラミドによる制御性T細胞の活性化、機能維持により移植した膵島細胞の生着延長効果が認められるかどうかについて、検討を予定していた。しかしながら、昨年度はマウスを用いた自家膵島移植の系が十分に確立できず十分な研究の進捗が得られなかった。今年度は動物種をマウスからラットに切り替え、十分な膵島を採取することに成功した。採取された膵島を用いて自か膵島移植実験を行ったところ、年度前半に、概ねラットモデルでの自家膵島移植モデルが確立した。年度後半で予定したセラミド投与実験を行った。具体的には、自家膵島移植モデルをプラセボ群、セラミド投与群、グリコシルセラミド投与群の3群に分けて、局所免疫動態や膵島生着に関して、フローサイトメトリー、及び、免疫組織学的に解析を実施した。その結果、セラミド投与群、グリコシルセラミド投与群において、プラセボ群と比較し、明らかな生着延長効果は確認出来ず、本研究の仮説を証明することができなかった。しかしながら、動物種を変更したために投与量が過小になった可能性があったため、次年度では、投与量の変更を行い、セラミドに関する至適投与量を検討し研究を継続する予定である。

    researchmap

  • Evaluation of FOXM1 and major signaling pathways as target molecule in pediatric malignant soft tissue tumor

    Grant number:17K11512

    2017.4 - 2021.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KUDA MASAAKI

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    Pediatric malignant soft tissue tumor has a poor prognosis, and a new therapeutic target is desired. Currently, Forkhead box M1 (FOXM1) is one of the most notable molecules as a new therapeutic target in major malignant tumors. In our past studies, we showed that FOM1 inhibition could be a new treatment option in studies of rhabdomyosarcoma and synovial sarcoma among pediatric malignant soft tissue tumors.
    In this study, we studied the relationship between malignant rhabdoid tumor (MRT) and FOXM1. We evaluated FOXM1 expression in 23 patients with MRT and the study of MRT cell lines demonstrates that FOXM1 may serve as a promising therapeutic target for MRT.

    researchmap

  • MTH1 expression in pediatric malignant solid tumor: a new therapeutic target

    Grant number:17K11511

    2017.4 - 2020.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Takemoto Junkichi

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    In this study, we evaluated 67 neuroblastomas. Immunohistochemistry for MTH1, 8-OHdG, OGG1 and MUTYH was performed. There was a significant correlation between MTH1and 8-OHdG expression. This result suggests that gene mutation was induced by oxidative stress and MTH1 may express as a repair protein in neuroblastoma.
    However, there was no significant correlation of MTH1 and 8-OHdG expression with other DNA repair enzymes, such as OGG1 and MUTYH. These result could not demonstrate the hypothesis that inhibition of MTH1expression induces cell death.

    researchmap

  • Examination of usefulness ofstem cells from human exfoliated deciduous teeth for hypoplastic lung of congenital diaphragmatic hernia

    Grant number:17K11513

    2017.4 - 2020.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KONDO Takuya

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    In the present study, we aimed to investigate the therapeutic effect of stem cell administration by creating a diaphragm hernia model by administering nitrophen to maternal mice.We tried to make a model mouse by orally administering 25 mg of nitrophen to a mouse on 8.5 days of pregnancy. Although some effects of the drug were observed, such as a decrease in fetal body weight, it was confirmed that the incidence of diaphragmatic hernia in fetuses was about 10% of the total, which was extremely small.

    researchmap

  • Elucidation of the etiology and development of the novel therapy using stem cells from human exfoliated deciduous teeth for Hirschsprung's disease and its allied disorders

    Grant number:16H02682

    2016.4 - 2020.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (A)

    Awarding organization:Japan Society for the Promotion of Science

    TAGUCHI Tomoaki

      More details

    Grant amount:\47450000 ( Direct Cost: \36500000 、 Indirect Cost:\10950000 )

    Among the above-mentioned disease groups, hypoganglionosis (HYPO), which has a poor prognosis, was focused first. HYPO is characterized by the presence of intestinal ganglion cells, but the number is extremely small. Similarly, a mouse (JF1) in which a decrease in intestinal nerve cells was used to elucidate the effect of stem cells from human exfoliated deciduous teeth (SHED). As a result, JF1 mice gained weight , indicating the effectiveness of SHED. Next, the characteristics of SHED derived from HYPO patients (HYPO-SHED) was analyzed. SHED is one of a mesenchymal stem cell (MSC), and HYPO-SHED has a phenotype consistent with MSC, and analysis was conducted on its proliferative potential and tumorigenity.

    researchmap

  • Establishment of new diagnostic system for pediatric malignant solid tumors by immunological glycan analysis

    Grant number:16K11347

    2016.4 - 2019.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Kinoshita Yoshiaki

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    There are three fractions (L1,L2,L3) in AFP (Alpha-feto protein) which is a typical tumor marker. Purpose of this project is to separate L2 fraction from L3 using an immunology and mass spectrography, and establish non-invasive simple diagnostic system.
    By immuno electrophoresis method using serum and tissue samples obtained from patients (target) with solid malignant tumors and benign diseases (control), physiological regression of L2 fraction was developed

    researchmap

  • Establishment of optimization method of dose and image quality in infant radiography

    Grant number:16K10322

    2016.4 - 2019.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Fujibuchi Toshioh

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    X-ray examinations have become essential in medical facilities. In particular, chest radiography is a frequently performed examination, which causes patient exposure. Children have higher radiation sensitivity than adults, and it is necessary to set appropriate imaging conditions and to evaluate exposure dose at the time of examination. In this study, we developed a polygon phantom that can be output by 3D printer for children with variable system from CT volume data, and evaluated the method of evaluating organ absorbed dose by Monte Carlo simulation, and clarified the printing condition of phantom that is 3D printed out close to the real body.

    researchmap

  • Development of an innovative surgical simulation /navigation system for neuroblastoma

    Grant number:15K10924

    2015.4 - 2018.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Souzaki Ryota

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    For the adrenal gland neuroblastoma, a three-dimensional organ model was created from a preoperative photographed CT image using a 3D printer. Using a resin that can be inserted into a trocar, a body was created, and it was used for simulation of tumor position in laparoscopic view, and examination of the best position of the trocar. We also modeled adrenal gland and liver model for liver metastasis cases of neuroblastoma and conducted surgical simulation.
    For hepatoblastoma, the same pediatric malignant tumor as neuroblastoma, a three-dimensional organ model was created from preoperative CT images. We confirmed the positional relationship between the portal vein and the hepatic vein and the position of the tumor, and simulated the resection line before surgery. We found the utility such as being able to more easily understand the anatomical information.

    researchmap

  • DEVELOPMENT OF A NURSING INTERVENTION MODEL TO IMPROVE THE QUALITY OF LIFE IN PREADOLESCENTS/ADOLESCENTS AND THEIR PARENTS AFTER LIVING DONOR LIVER TRANSPLANT

    Grant number:26463414

    2014.4 - 2022.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Fujita Ayaka

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    The aim of this study was to develop a model of nursing assistance and problem solving to improve the quality of life of children and parents from school age to adolescence after liver transplantation. Child and family monitoring indicators were developed based on the results of a survey of children and parents, interviews, and a review of the literature. The survey results and literature review led to a conceptual framework, nursing assistance model, and pattern-specific nursing assistance guidelines for improving the quality of life of children and parents from late school age to adolescence after living donor liver transplantation. The developed nursing assistance model was practiced, evaluated, and revised, and the content was refined to construct a nursing assistance model for improving the quality of life of children and parents from late school age to adolescence after liver transplantation.

    researchmap

  • Development of a grief care program for families who have lost their children ~ Action research through the story of loss and grief~

    Grant number:26502006

    2014.4 - 2017.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Hamada Yuko, SASATUKI Momoko, KYOGOKU Shinji, YAMASHITA Ikuyo

      More details

    Grant amount:\5070000 ( Direct Cost: \3900000 、 Indirect Cost:\1170000 )

    This study is aimed at revealing need for the grief care and planning a further support program. Through interviews to the parents losing their kids, following things seem common and often-heard opinions; “We don’t want to think he/she (kids) never exist from the very beginning.” “Wanna you to know and understand him/her.” “Want a place where I am able to explain myself.”
    In this grief care program, four times of group interviews and a single event ware done. In addition, a support book was also prepared.

    researchmap

  • Evaluation of FOXM1 and related protein expression as target molecule in refractory pediatric malignant soft tissue tumor

    Grant number:26462708

    2014.4 - 2017.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KUDA MASAAKI

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    Pediatric malignant soft tissue tumor has a poor prognosis, and a new therapeutic target is desired. Currently, Forkhead box M1 (FOXM1) is one of the most notable molecules as a new therapeutic target in major malignant tumors.
    We evaluated FOXM1 expression in 92 patients with rhabdomyosarcoma (RMS) and 106 synovial sarcoma (SS) among pediatric malignant soft tissue tumors. We showed that FOXM1 expression is associated with poor prognosis. In RMS, FOXM1 correlated with VEGF expression and angiogenesis. In cDNA microarray analysis of SS cases, we showed that cell cycle related gene expression correlates with FOXM1 expression. We showed that FOM1 inhibition could be a new treatment option in studies of cell lines of each tumor.

    researchmap

  • Development of non-invasive diagnosis and novel therapies for pediatric solid tumor

    Grant number:25253095

    2013.4 - 2016.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (A)

    Awarding organization:Japan Society for the Promotion of Science

    Hosoi Hajime, NAKAGAWARA Akira, HIYAMA Eiso, TAJIRI Tatsuro, Hojo Hiroshi, TAKIMOTO Tetsuya, IEHARA Tomoko, TAKITA Junko, KINOSHITA Yoshiaki, OKITA Hajime, HISHIKI Tomoro, TSUCHIYA Kunihiko, MIYACHI Mitsuru

      More details

    Grant amount:\44720000 ( Direct Cost: \34400000 、 Indirect Cost:\10320000 )

    The aim of this project is to develop a novel non-invasive diagnostic methods and therapeutic strategy for pediatric cancer, which can be translated into the upcoming clinical trial. We have identified 1) potent serum-based biomarkers for the therapeutic stratification of neuroblastoma and rhabdomyosarcoma, 2)a potent delivery system using human mesenchymal stem cells targeting neuroblastoma, 3) a novel immunotherapeuric strategy for pediatric cancers using peptide vaccine system, anti PD-1 antibody, or NKT cell therapy, 4) novel molecular-based stratification system for pediatric cancers detected by next generation sequencing analysis.

    researchmap

  • The development of new molecular target treatment drug for neuroblastoma using MYCN transgenic mouse

    Grant number:24592698

    2012.4 - 2015.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    SOUZAKI Ryota, KINOSHITA Yoshiaki, TAGUCHI Tomoaki, KOHASHI Kenichi, MIYOSHI Kina, TAJIRI Tatsuro

      More details

    Grant amount:\5330000 ( Direct Cost: \4100000 、 Indirect Cost:\1230000 )

    We used the MYCN transgenic mouse which was a neuroblastoma model mouse for determining the possibility of the new molecular target in the neuroblastoma. The tumor samples were obtained from homo and hetero MYCN transgenic mouse. The pathological examination was performed for homo and hetero MYCN transgenic mouse samples. And Hh signal proteins (Sonic Hh, GLi1, Patched) were dertermined using immunostaining method. H.E. stains of both samples were shown undifferentiated subtype of neuroblastoma and there were not differences between both groups. Sonic Hh, Patched was strong positive, but the GLi1 was negative in both group. From the results, there was not difference between two groups, even if the survival rate of each group were different. In the human neuroblastoma specimen, the GLi1 was strongly positive. However, in MYCN transgenic mouse, GLi1 was negative. Therefore the Hh signal activation was different between human neuroblastoma and MYCN trancegenic mouse.

    researchmap

  • Prospective study of how NICU high illuminance environment influence the preterm infants' sleep-wake rhythm formation and physical, mental development

    Grant number:23601012

    2011.4 - 2016.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    SHINKODA HARUMI, KAKU Tunehisa, KINOSHITA Yoshiaki, SUETHUGU Yoshiko, KIYOHARA Chikako, KOGA Yasuko, ASAMI Eriko, MATHUMOTO Kazuya, OCHIAI Masayuki, YUMOTO Yasuo, ANAI Ken, SHIRAMIZU Masako, MITHUTAKE Reiko, UENO Fujimi, ARATA Hiroki, INAGAKI Shiho, UEDAN Kiyomi, OOTA Ayuko

      More details

    Grant amount:\5590000 ( Direct Cost: \4300000 、 Indirect Cost:\1290000 )

    The objective is to get suggestion to construct the optimal developmental care for premature infants in the NICU. We evaluate their quality of sleep, sleep-wake rhythm and revealed the characteristics of physiological daily variation. In addition, we carried out interventional observation for simulated intrauterine environment. As a result, we recognized decline trend in amount of activity within dark NICU environment (<50Lux). There are no clear differences in quality of sleep. By the frequency analysis of the noise, infants cried more when noise are above 70-80dB. This result meant that noise stimulate infants to awake rather than light.

    researchmap

  • Action Research to create a place for children with life threatening illness:An exploration of Children's Hospice in Japan

    Grant number:22610010

    2010.4 - 2014.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    HAMADA YUKO

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    This study was Action Research for exploration the possibility of Children's Hospice in Japan. The purpose of this research was to clarify the experiences of children with life threatening illness and their parents, and their palliative care needs. Palliative care needs of them are needs for their development. Especially, QOL in infancy and after graduate high school were decreasing. We have concerned with three cases of children in terminal stage and found not only medical care but also the necessity of children's and family developmental support. Next, we made some citizen forum and meetings as enlighten programs for pediatric palliative care (children's hospice), and some programs to support the children's and the family's QOL. Finally, we made a network for children's hospice through cooperating with not only heath care providers but also ordinary people and people in multiple ranges. Through the process of action research, a direction for children's hospice in Japan were showed.

    researchmap

  • GLYPICAN 3 targeted therapy in pediatric solid malignant tumors.

    Grant number:22591980

    2010 - 2012

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KINOSHITA Yoahiaki, TAGUCHI Tomoaki, TAJIRI Tatsuro, SUZAKI Ryota, TANAKA Sakura

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    【Purpose】The purpose of this study is to analyze the usefulness of Glypican3 as a novel diagnostic tumor marker for pediatric solid malignant tumor, and to establish the new diagnostic system. Final goal is to develop the immuno-genetic therapy targeted for the Glypican3.【Method】The immunohistochemical analysis and serological analysis of Glypican3 and AFP was performed for the pathological materials and patient’s serum. 【Results】Immunohistochemlically and serologically, most cases of hepatoblastoma and malignant germ cell tumor showed positive for Glypican3, and one of thirds Wilms tumor, alveolar type rhabdomyosarcoma and undifferentiated sarcoma were also positive. Concerning AFP, most cases of hepatoblastoma and malignant germ cell tumor showed positive. Concerning non-neoplastic patients’, serum Glypican 3 was high just after birth and gradually decreased according to their age. The level normalized by the 1 year.【Discussion】Glypican3 was confirmed as the novel diagnostic marker for pediatric solid malignant tumors. Based on this research, for the refractory cases of pediatric solid malignant tumor over 1 year, such new treatment immuno-genetic therapy targeted forGlypican 3 will be expected.

    researchmap

  • New treatment using gene induction and regenerative medicinefor diaphragmatic agenesis

    Grant number:21390475

    2009 - 2012

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    TAGUCHI Tomoaki, MASUMOTO Koji, NONAKA Kazuaki, NAGATA Koji, IEIRI Satoshi, TAJIRI Tatsuro, KINOSHITA Yoshiaki

      More details

    Grant amount:\17290000 ( Direct Cost: \13300000 、 Indirect Cost:\3990000 )

    Intrapulmonary mesenchymal stem cells (MSC) were administered to the rat with nitrophen-induced diaphragmatic hernia. As a result, PCNA positive cells are increased.DNA was extracted from the 20 patients and parents of congenital diaphragmatic hernia. The microdeletion of TCTE3 was detected. This might be the responsible gene for congenital diaphragmatic hernia.Abdominal muscle flap method was performed for the reconstructive surgery in 11 cases with recurrent diaphragmatic hernia. All of the patients showed good outcome.Liver-like cells were induced from SHED. We are just starting to make the sheet of the striated muscle cells derived from SHED.

    researchmap

  • New strategy for congenital diaphragmatic hernia based on the metabolism of extracellular matrix

    Grant number:19592061

    2007 - 2008

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    MASUMOTO Kouji, TAGUCHI Tomoaki, KINOSHITA Yoshiaki, NAGATA Kouji

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • Diagnostic value of Glypican 3 as a new serum tumor marker for Wilms tumor

    Grant number:19592060

    2007 - 2008

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    KINOSHITA Yoshiaki, TAGUCHI Tomoaki, TAJIRI Tatsuro, SOUZAKI Ryota

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    researchmap

  • Dendritic cell-based immunotherapy for pediatric solid malignant tumor using the novel vector

    Grant number:18591955

    2006 - 2008

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    TAJIRI Tatsuro, TAGUCI Tomoaki, SUEISHI Katsuo, YONEMITSU Yoshikazu, KINOSHITA Yoshiaki

      More details

    Grant amount:\4040000 ( Direct Cost: \3500000 、 Indirect Cost:\540000 )

    researchmap

  • Analysis of a novel prognostic factor of neuroblastoma detected by microarray system

    Grant number:17591864

    2005 - 2006

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    HIGASHI Mayumi, TAJIRI Tatsuro, TAGUCHI Tomoaki, SUITA Sachiyo, SUITA Yoshiaki, TAKAHASHI Yukiko

      More details

    Grant amount:\3500000 ( Direct Cost: \3500000 )

    We compared gene expressions between favorable and unfavorable neuroblastomas by microarray system, and it showed about 400 of unfavorable tumor dominant genes and about 40 of favorable tumor dominant genes. A high expression of neuronatin (Nnat) gene in favorable neuroblastomas were found. Neuronatin is a gene which is considered to relate to the neurogenesis, and the expression appears in nervous systems from the hindbrain to the peripherals during the prenatal periods. It is an imprinted gene, highly conserved in mammalian spices. The neuronatin mRNA expression was investigated in 70 of neuroblastoma samples by quantitative RT-PCR, and the expression was significantly high in favorable groups than unfavorable groups. Although the detailed function is not revealed, the high expressions of neuronatin were found to be associated with good prognoses in neuroblastoma, which might indicate the tumor differentiation, and its expressions in unfavorable tumors were supposed to be epigenetically suppressed.

    researchmap

  • Effect of growth factor regarding lung development of congenital diaphragmatic hernia

    Grant number:16390504

    2004 - 2006

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (B)

    Awarding organization:Japan Society for the Promotion of Science

    SUITA Sachiyo, TAGUCHI Tomoaki, MASUMOTO Kouji, KINOSHITA Yoshiaki, NONAKA Kazuaki

      More details

    Grant amount:\14500000 ( Direct Cost: \14500000 )

    Insulin-like growth factors (IGFs) are one of the major growth factors related to lung development. The purpose of this study is to analyze the effect of IGF using organ cultured lungs.
    The lungs were dissected from E11 to E18 mice. Total RNA was then extracted from those lungs. The expression of IGF and its receptors was analyzed by RT-PCR.
    The lungs dissected from E17 mice were cultured in the BGjb medium for 48 hours. The lungs were divided into the following three groups ; the lungs were cultured only by the medium (group I), or the medium containing either IGF-1 (group II) or IGF-2 (group III). The expressions of TTF-1,Sp-C, and alpha-SMA were analyzed by both RT-PCR and immunohistochemistry.
    The m-RNA expression of IGF-1 receptor was observed to be higher from E16 to E18 than at any other embryonic stages. TTF-1,Sp-C and alpha-SMA were more highly expressed in groups II and III than in those of group I. TTF-1,Sp-C, and alpha-SMA positive cells were increased in group II and III compared to group I.
    Based on our findings, IGF is therefore suggested to induce alveolar maturation in the late stages of fetal lung development. IGF is considered to be one of the candidates for promoting lung development in patients with congenital diaphragmatic hernia.

    researchmap

  • ウイルムス腫瘍の発生、発育におけるβ-カテニン遺伝子、WT1遺伝子の関与

    Grant number:16791083

    2004 - 2005

    System name:科学研究費助成事業

    Research category:若手研究(B)

    Awarding organization:日本学術振興会

    木下 義晶

      More details

    Grant amount:\3400000 ( Direct Cost: \3400000 )

    β-カテニンのoncogenesisへの関与は小児悪性腫瘍においては近年、肝芽腫の発生に強く関与する報告がなされている。肝芽種の約50%の症例においてβ-カテニンの変異が検出されており、その発生への関与が示唆されている。しかし他の小児固形悪性腫瘍へのβ-カテニンの関与は今のところ不明である。ウイルムス腫瘍の発生にはWT1遺伝子異常が関与するとされてきたが、その頻度は10%程度であり、oncogenesisにどのように関わっているかの詳細は未だ不明である。近年、β-カテニンもウイルムス腫瘍に15%程度の頻度で異常を認めるとされており、本研究ではβ-カテニン遺伝子とWT1遺伝子のウイルムス腫瘍の発生ならびに発育における関与を明らかにすることを目的とした。1964年より2005年の間に九州大学小児外科教室において経験されたウィルムス腫瘍40例を対象とし、免疫組織学的にβ-カテニン、WT1遺伝子の発現を検討した。β-カテニンについては細胞膜に陽性を示したものが38例(100.0%)、細胞質に陽性を示したものが35例(92.1%)、核内移行を示したものが9例(23.7%)であった。組織型別での陽性率は腎芽型成分に35例(92.1%)、上皮型細胞成分に12例(31.6%)、問葉型成分には2例(5.3%)の陽性率であった。WT1については細胞質に陽性を示したものが30例(79.0%)、核内移行を示したものが22例(57.9%)であり、組織型別での陽性率は、腎芽型細胞成分に21例(55.2%)、上皮型細胞成分に14例(36.8%)、間葉成分には3例(7.9%)の陽性率であった。β-カテニンにて核内移行を示した9例は全例WT1にても核内移行を示した。さらに組織内におけるDNAの発現と変異を調べるためにMicrodissectionにてこれらのパラフィン標本より組織型別にDNAを抽出し、検出されたDNAをSequencerを用いてdirect sequenceを行った。しかしqualityの高いDNAを得ることができず、有意な結果を得ることはできなかった。以上よりウィルムス腫瘍におけるβ-カテニン、WT1遺伝子のoncogenesisへの関与に関しては免疫組織学的検討により同時に核内移行を示す約20%の症例において何らかの関与があることが示唆された。

    researchmap

  • 乳児神経芽腫マススクリーニング症例における遺伝子異常の高感度解析

    Grant number:14657454

    2002 - 2004

    System name:科学研究費助成事業

    Research category:萌芽研究

    Awarding organization:日本学術振興会

    水田 祥代, 田尻 達郎, 木下 義晶, 野口 伸一

      More details

    Grant amount:\3400000 ( Direct Cost: \3400000 )

    乳児神経芽腫マススクリーニングによる発見症例は、その生存率は98%と非常に高く、一見その目的は達成されているようにみえるが、マス検査陰性後に臨床的に発見される症例(マス陰性例)が数多く存在し、それらは進行症例が多く、予後不良である(J Pesiatr Surg.1998:33,1674-1678)。日本以外で全国規模でマスを施行している国は世界になく、多数のマス発見例及びマス陰性例の詳細な生物学的特性の解析と臨床経過の検討は、マスの有効性の評価及びマス症例の治療方針の決定に直結するだけでなく、神経芽腫全体の生物学的多様性を究明するデータとなることが予想される。
    現在までの研究で、神経芽腫の遺伝子異常を高感度かつ迅速に解析を行う手法としてMYCN amp.と1p del.に関してflourescence in situ hybridization(FISH)による解析を確立し(J Pediatr Surg,1999:34,1615-1619)、また、MYCN amp.と17q gainに関してReal Time PCR(TaqMan^<TM>PCR)による解析を確立した(Cancer Lett.2001:10,89-94)。
    MYCN amp.に関しては、今年度の研究によりFISHとReal Time PCRによる組み合わせが最も正確にamplificationの状態を評価することができて、神経芽腫の悪性度と非常に相関している結果を得て発表した(J Pediatr Surg.2004:39,63-68)。
    さらに、定量的PCRによりMYCN amp.,17 q gain,1p del.,11p del.,14q del.の同時解析を行った結果、MUCN amp.,17q gain,1p delの高感度解析の組み合わせにより、乳児神経芽腫の生物学的悪性度の層別化が可能であり、マス休止後の臨床的に発見される乳児神経芽腫の治療方針に決定に有意義であると考えられた。

    researchmap

▶ display all

 

Teaching Experience

  • 医学序説 I

    2022
    Institution name:新潟大学

  • 医学序説 II

    2021
    Institution name:新潟大学

  • 臓器別講義・演習Ⅱ

    2020
    Institution name:新潟大学

  • 臨床医学講義(集中)

    2020
    Institution name:新潟大学

  • 医学序説 I

    2020
    Institution name:新潟大学